These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28774261)

  • 1. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
    Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
    BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
    Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor J; Loveday S; Powell E; Spencer J; Wodak A
    Int J Epidemiol; 2003 Oct; 32(5):717-24. PubMed ID: 14559738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.
    Smith DJ; Combellick J; Jordan AE; Hagan H
    Int J Drug Policy; 2015 Oct; 26(10):911-21. PubMed ID: 26298331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.
    Kileng H; Bernfort L; Gutteberg T; Moen OS; Kristiansen MG; Paulssen EJ; Berg LK; Florholmen J; Goll R
    BMC Infect Dis; 2017 Sep; 17(1):624. PubMed ID: 28915795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
    Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
    Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    Liver Int; 2022 Oct; 42(10):2145-2153. PubMed ID: 35753064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projections of the current and future disease burden of hepatitis C virus infection in Malaysia.
    McDonald SA; Dahlui M; Mohamed R; Naning H; Shabaruddin FH; Kamarulzaman A
    PLoS One; 2015; 10(6):e0128091. PubMed ID: 26042425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
    Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
    Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
    Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
    J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group.
    Law MG
    J Gastroenterol Hepatol; 1999 Nov; 14(11):1100-7. PubMed ID: 10574138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections.
    Bennett H; McEwan P; Sugrue D; Kalsekar A; Yuan Y
    PLoS One; 2015; 10(5):e0125846. PubMed ID: 25938458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
    Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Mabileau G; Dhersin JS; Yazdanpanah Y
    J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History of Hepatitis C.
    Lingala S; Ghany MG
    Gastroenterol Clin North Am; 2015 Dec; 44(4):717-34. PubMed ID: 26600216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates on HCV disease burden worldwide - filling the gaps.
    Wedemeyer H; Dore GJ; Ward JW
    J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.
    Mühlberger N; Schwarzer R; Lettmeier B; Sroczynski G; Zeuzem S; Siebert U
    BMC Public Health; 2009 Jan; 9():34. PubMed ID: 19161623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of hepatitis C in England.
    Sweeting MJ; De Angelis D; Brant LJ; Harris HE; Mann AG; Ramsay ME
    J Viral Hepat; 2007 Aug; 14(8):570-6. PubMed ID: 17650291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling and calibration of the hepatitis C epidemic in Australia.
    Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
    Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.